(Q45003499)

8 December 2017

Prevalence, care, and outcomes for patients with diet-controlled diabetes in general practice: cross sectional survey (English)

1 reference

8 December 2017

0 references

1

1 reference

8 December 2017

M Pringle

2

1 reference

PubMed ID

15288740

8 December 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

8 December 2017

1 reference

8 December 2017

364

1 reference

8 December 2017

423-428

1 reference

8 December 2017

9432

1 reference

Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study

8 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916765-2

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916765-2

7 January 2021

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916765-2

7 January 2021

Optimizing treatment of hypertension in patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916765-2

7 January 2021

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916765-2

7 January 2021

Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916765-2

7 January 2021

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916765-2

7 January 2021

Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916765-2

7 January 2021

Retrospective review of care and outcomes in young adults with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916765-2

7 January 2021

Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916765-2

7 January 2021

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916765-2

7 January 2021

Use of Read codes in diabetes management in a south London primary care group: implications for establishing disease registers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916765-2

7 January 2021

The electronic patient record in primary care--regression or progression? A cross sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916765-2

7 January 2021

Modifiable cardiovascular risk factors in adults with diabetes: prevalence and missed opportunities for physician counseling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916765-2

7 January 2021

Shifting of care for diabetes from secondary to primary care, 1990-5: review of general practices

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916765-2

7 January 2021

10.1016/S0140-6736(04)16765-2

Identifiers

DOI

1 reference

8 December 2017

1 reference

PubMed ID

15288740